Cholera
Ron Smith, MD
Cholera in the News
Under a magnification of 320X, and processed using Leifson flagella stain, this digitally enhanced photomicrograph depicts numerous, Vibrio cholerae bacteria. This staining method makes it easy to see the flagellum emanating from each organism.
Quick Overview
TABLE 32.2.4 Centers for Disease Control and Prevention Case Definition for Monkeypox
Ryan, Edward, T. et al. Hunter's Tropical Medicine and Emerging Infectious Diseases E-Book. Available from: Elsevier eBooks+, (10th Edition). Elsevier - OHCE, 2019.
Incubation period
Prodrome period
Symptom
Fever
Malaise
Headache
Lymphadenopathy
Lesions
Depth (diameter in mm)
Distribution
Evaluation
Time to desquamation
Frequency of lesions on palms or soles of feet
Monkeypox
7–17
1–4
Moderate
Moderate
Moderate
Moderate
Superficial to deep (4–6)
Centrifugal (mainly)
Homogeneous rash
14–21
Common
Smallpox
7–17
2–4
Severe
Moderate
Severe
None
Deep (4–6)
Centrifugal
Homogeneous rash
14–21
Common
Chickenpox
12–14
0–2
Mild or none
Mild
Mild
None
Superficial (2–4)
Centripetal
Heterogeneous rash
6–14
Rare
CRITERIA FOR CLASSIFICATION
Clinical Criteria
• Rash (macular, papular, vesicular, or pustular; generalized or localized; discrete or confluent)
• Fever (subjective or measured temperature of ≥99.3°F [≥37.4°C])
• Other signs and symptoms:
• Chills and/or sweats
• Headache
• Backache
• Lymphadenopathy
• Sore throat
• Cough
• Shortness of breath
Epidemiologic Criteria
• Exposure * to an exotic wild mammalian pet † obtained on or after April 15, 2003, with clinical signs of illness (e.g., conjunctivitis, respiratory symptoms, and/or rash)
• Exposure * to an exotic or wild mammalian pet † with or without clinical signs of illness that has been in contact with either a mammalian pet § or a human with monkeypox
• Exposure ¶ to a suspect, probable, or confirmed human case of monkeypox
Laboratory Criteria
• Isolation of monkeypox virus in culture
• Demonstration of monkeypox virus DNA by polymerase chain reaction testing of a clinical specimen
• Demonstration of virus morphologically consistent with an Orthopoxvirus by electron microscopy in the absence of exposure to another Orthopoxvirus
• Demonstration of presence of Orthopoxvirus in tissue using immunohistochemical testing methods in the absence of exposure to another Orthopoxvirus
CASE CLASSIFICATION
Suspect Case
• Meets one of the epidemiologic criteria, AND
• Fever or unexplained rash, AND
• Two or more signs or symptoms with onset of first sign or symptoms less than 21 days after last exposure meeting epidemiologic criteria
Probable Case
• Meets one of the epidemiologic criteria, AND
• Fever, AND
• Vesicular-pustular rash with onset of first sign or symptom less than 21 days after last exposure meeting epidemiologic criteria, OR
• If rash is present but the type is not described, demonstrates elevated levels of IgM antibodies reactive with Orthopoxvirus between at least days 7–56 after rash onset
Confirmed Case
• Meets one of the laboratory criteria
EXCLUSION CRITERIA
• An alternative diagnosis can fully explain the illness, OR
• The case was reported on the basis of primary or secondary exposure to an exotic or wild mammalian pet or a human (see epidemiologic criteria) subsequently determined not to have monkeypox, provided other possible epidemiologic exposure criteria are not present, OR
• A case without a rash does not develop a rash within 10 days of onset of clinical symptoms consistent with monkeypox.
• The case is determined to be negative for non-variola generic Orthopoxvirus by polymerase chain reaction testing of a well-sampled rash lesion by the approved Laboratory Response Network (LRN) protocol, OR
• The case is determined to have undetectable levels of IgM antibody during the period 7–56 days after rash onset.